FdaApplication
ANDA 210278
Identifiers
- fda_app_no: ANDA210278
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2021-02-01 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOPIRAMATE | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
5 products